Needham & Company
-
TRACON Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference
-
TRACON Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference
-
Notable Analyst Rating Changes 2/24: (COH) (DSW) (NCLH) Upgraded; (HFC) (HII) (S) Downgraded
-
Needham & Company Starts Tracon Pharmaceuticals (TCON) at Buy
-
TRACON Pharmaceuticals (TCON) IPO Opens Modestly Lower
-
TRACON Pharmaceuticals (TCON) Prices 3.6M Common IPO at $10/Share
-
TRACON Pharmaceuticals Announces Pricing of Initial Public Offering
-
TRACON Pharmaceuticals (TCON) Files $57.5M IPO

